The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 170.20
Bid: 169.60
Ask: 170.20
Change: 6.20 (3.78%)
Spread: 0.60 (0.354%)
Open: 162.00
High: 170.60
Low: 162.00
Prev. Close: 164.00
FORT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

15 Jun 2021 09:56

RNS Number : 9401B
Forterra plc
15 June 2021
 

15 June 2021

Forterra plc (the "Company")

Director / PDMR Shareholdings

Following the vesting on 26 April 2018 of share options granted to to certain senior managers including persons discharging managerial responsibility ("PDMRs") under the 2016 Deferred Annual Bonus Plan ("DABP"), the Company was notified on the 14 June 2021 that on the same day the following exercise took place:

Adam Smith, Commercial Director exercised options granted under the DABP as laid out below and paid the appropriate tax and national insurance liabilities separately.

Name

Status

Number of shares exercised

Exercise Date

Number of shares retained

Beneficial interest

% of ISC

Adam Smith

PDMR

17,306

14/6/21

17,306

35,767

< 1%

The 2016 DABP awards represent the deferral into ordinary shares of the IPO Bonus to which those individuals become entitled to following the successful admission of the Company's ordinary share capital to the Official List of the Financial Conduct Authority and to trading on the London Stock Exchange plc's main market for listed securities, which occurred on 26 April 2016, as disclosed in the Company's prospectus (the "Prospectus") dated 21 April 2016 subject to the participant being an employee at the time of vesting.

No consideration was paid for the grant of the awards which are structured as nominal (1p) cost options although this sum was waived by the Company on exercise. The number of options exercised also includes a dividend equivalent in addition to the options initially granted in accordance with the rules of the scheme.

No new shares were issued in respect of these transactions with shares being transferred to the individuals from the Forterra Employee Benefit Trust.

The above notification is intended to satisfy the Company's obligations under Article 19 of the Market Abuse Regulations.

Enquiries

Forterra plc:

+44 (0) 1604 707 600

Ashley Thompson (Company Secretary)

FTI Consulting:

+44 (0) 20 3727 1340

Richard Mountain/Nick Hasell

Further information relating to the Company and its group can be found at www.forterraplc.co.uk.

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Adam Smith

2.

Reason for the notification

a)

Position/status

PDMR (Commercial Director)

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Forterra plc

b)

LEI

213800O5DD6ATBVJAD23

4.

Details of the transaction(s):

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

 

GB00BYYW3C20

b)

Nature of the transaction

Acquisition of shares for no consideration pursuant to the exercise of nominal cost options (with the 1p option cost waived by the Company) granted under the DABP scheme on 1 June 2016 and vesting on 26 April 2018

c)

Price(s) and volume(s)

Transaction

Price(s)

Volume(s)

 

£Nil

 

 

£Nil

 

17,306 options vesting

 

17,306 shares acquired

d)

Aggregated information

 

Transaction

Price(s)

Volume(s)

Total

 Exercise

£Nil

17,306

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGPUWAQUPGURA
Date   Source Headline
30th Jun 20225:27 pmRNSTotal Voting Rights and Capital
30th Jun 20227:00 amRNSTransaction in Own Shares
29th Jun 20227:00 amRNSTransaction in Own Shares
28th Jun 20227:30 amRNSTransaction in Own Shares
28th Jun 20227:00 amRNSShare buyback programme
27th Jun 20224:51 pmRNSHolding(s) in Company
27th Jun 20227:00 amRNSTransaction in Own Shares
24th Jun 20227:00 amRNSTransaction in Own Shares
23rd Jun 20227:00 amRNSTransaction in Own Shares
22nd Jun 20227:00 amRNSTransaction in Own Shares
21st Jun 20227:00 amRNSTransaction in Own Shares
20th Jun 20227:00 amRNSTransaction in Own Shares
17th Jun 20227:00 amRNSTransaction in Own Shares
16th Jun 20227:00 amRNSTransaction in Own Shares
15th Jun 20227:00 amRNSTransaction in Own Shares
14th Jun 20227:00 amRNSTransaction in Own Shares
13th Jun 20227:00 amRNSTransaction in Own Shares
10th Jun 20227:00 amRNSTransaction in Own Shares
9th Jun 20227:00 amRNSTransaction in Own Shares
8th Jun 20227:00 amRNSTransaction in Own Shares
7th Jun 20223:47 pmRNSEmployee Benefit Trust Share Purchase
7th Jun 20227:00 amRNSTransaction in Own Shares
1st Jun 20229:52 amRNSTotal Voting Rights
1st Jun 20227:00 amRNSTransaction in Own Shares
31st May 202212:02 pmRNSHolding(s) in Company
31st May 20227:00 amRNSTransaction in Own Shares
30th May 20227:00 amRNSTransaction in Own Shares
27th May 20227:00 amRNSTransaction in Own Shares
26th May 20227:00 amRNSTransaction in Own Shares
25th May 202210:26 amRNSProgressive publishes new research
25th May 20227:00 amRNSTransaction in Own Shares
24th May 20224:30 pmRNSHolding(s) in Company
24th May 20224:15 pmRNSAnnual General Meeting 2022 Results
24th May 20228:00 amRNSTransaction in Own Shares
24th May 20227:00 amRNSBoard change
24th May 20227:00 amRNSAGM trading update
23rd May 20227:00 amRNSTransaction in Own Shares
20th May 20227:00 amRNSTransaction in Own Shares
19th May 20227:00 amRNSTransaction in Own Shares
18th May 20227:00 amRNSTransaction in Own Shares
17th May 20227:00 amRNSTransaction in Own Shares
16th May 20227:00 amRNSTransaction in Own Shares
13th May 20227:00 amRNSTransaction in Own Shares
12th May 20227:00 amRNSTransaction in Own Shares
11th May 20227:00 amRNSTransaction in Own Shares
10th May 20227:00 amRNSTransaction in Own Shares
9th May 20227:00 amRNSTransaction in Own Shares
6th May 20227:00 amRNSTransaction in Own Shares
5th May 20227:00 amRNSTransaction in Own Shares
4th May 20221:04 pmRNSEmployee Benefit Trust Share Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.